| 000 | 01965nam a2200289 4500 | ||
|---|---|---|---|
| 001 | ESSALUD | ||
| 005 | 20260817163214.0 | ||
| 007 | ta | ||
| 008 | t pe ||||| |||| 00| 0 spa d | ||
| 040 | _aBMG | ||
| 041 | _aeng | ||
| 100 |
_aShelley, Donna _eAutor _954129 |
||
| 245 | _aEvidence-based tobacco-cessation strategies for low-and middle-income countries | ||
| 300 | _apáginas: 684-693 | ||
| 520 | _aTobacco use is the leading cause of preventable death globally, claiming more than 7 million lives each year. The burden of disease is highest in low- and middle-income countries, where more than 80% of the world’s 1.3 billion tobacco users reside. The World Health Organization (WHO) defines six proven strategies to reduce tobacco use, referred to by the acronym MPOWER, with one of the strategies being to offer tobacco users help with quitting. Many low- and middle-income countries provide tobacco-cessation services; however, only 31 meet the WHO best practice, defined as providing both cost-covered behavioral interventions and pharmacotherapy. In this article, case studies from India and Vietnam illustrate how cross-country differences in tobacco-related sociocultural norms, tobacco-use patterns (e.g., smokeless tobacco or water pipes), the tobacco-control regulatory environment, industry influence, and health care system financing shape treatment access and uptake. | ||
| 650 |
_aPRESTACIONES DE SERVICIOS DE SALUD _954130 |
||
| 650 |
_aADICCION _953681 |
||
| 650 |
_aPOLÍTICA SANITARIA INTERNACIONAL _954131 |
||
| 650 |
_aMEDICINA CLÍNICA AMBULATORIA _953762 |
||
| 650 |
_aSALUD PÚBLICA GENERAL _954132 |
||
| 700 |
_aRigotti, Nancy A. _954133 |
||
| 700 |
_aMurthy, Pratima _954134 |
||
| 700 |
_aVan Minh, Hoang _954135 |
||
| 700 |
_aSiddiqi, Kamran _954136 |
||
| 773 | 0 |
_022717 _922647 _dMassachusetts NEJM Group _oNEJM010 _tThe New England Journal of Medicine _wESSALUD _x0028-4793 |
|
| 942 |
_cARTICULOS _e2026-08-17 _zSQB |
||
| 999 |
_c22828 _d22828 |
||